NASDAQ · Financial Statements

VivoSim Labs, Inc. (VIVS) Revenue, Earnings & Financial Statements

$0.12 NASDAQ: VIVS Market Cap $1.99M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

VivoSim Labs, Inc. most recently reported annual revenue of $0, a net loss of $14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

VivoSim Labs, Inc.: Revenue fell from $4.0M in 2017 to $0 in 2026, a change of -100.0% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -911.9% to -8567.9%, a shift of -7656.0 percentage points; the most recent year shows a net loss of $14.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$4.0M$5.0M$3.0M$2.0M$0$2.0M$0$0$0$0
Operating Expenses$43.0M$40.0M$30.0M$24.0M$17.0M$13.0M$18.0M$15.0M$13.0M$11.0M
Operating Profit−$39.0M−$35.0M−$27.0M−$21.0M−$17.0M−$11.0M−$18.0M−$15.0M−$13.0M−$11.0M
Operating Margin-911.9%-766.3%-882.4%-977.9%—-765.3%-4792.2%-13840.4%-8761.1%-8567.9%
Other Income$0$0$1.0M$3.0M$0$0$0$0$10.0M−$2.0M
Interest$0$0$0$0$0$0$0$0$0$0
Depreciation$1.0M$1.0M$1.0M$1.0M$0$0$0$0$0$0
Profit Before Tax−$38.0M−$35.0M−$27.0M−$19.0M−$17.0M−$11.0M−$17.0M−$15.0M−$2.0M−$14.0M
Tax rate (%)-0.1%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.1%0.0%
Net Profit−$38.0M−$35.0M−$27.0M−$19.0M−$17.0M−$11.0M−$17.0M−$15.0M−$2.0M−$14.0M
EPS−$94.38−$77.89−$55.40−$34.66−$29.25−$15.78−$23.77−$19.25−$1.70−$5.35

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$4.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Operating Profit−$4.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M−$3.0M
Operating Margin-73600.0%-10675.9%-8682.0%-8693.3%-14450.0%-6184.3%-7878.4%-9410.7%-10576.9%-7967.5%-15327.8%-6502.0%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$4.0M−$3.0M−$3.0M−$3.0M−$3.0M$7.0M−$3.0M−$3.0M−$3.0M−$6.0M−$1.0M$0
Tax rate (%)0.0%0.0%-0.1%0.0%0.0%0.0%0.0%-0.1%0.0%0.0%-0.2%0.0%
Net Profit−$4.0M−$3.0M−$3.0M−$3.0M−$3.0M$7.0M−$3.0M−$3.0M−$3.0M−$6.0M−$1.0M$0
EPS−$4.74−$3.07−$2.74−$1.70−$2.29$4.68−$1.94−$1.74−$1.84−$2.21−$0.25−$0.03

Over the 10 years reported for VivoSim Labs, Inc., cash stood at $5.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.33 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$69.0M$50.0M$41.0M$28.0M$40.0M$33.0M$20.0M$6.0M$15.0M$7.0M
Current Assets$65.0M$47.0M$39.0M$28.0M$38.0M$30.0M$17.0M$4.0M$12.0M$7.0M
Cash$63.0M$44.0M$36.0M$27.0M$37.0M$29.0M$15.0M$3.0M$11.0M$5.0M
Inventory$1.0M$1.0M$0$0$0$0$0$0$0$0
Receivables$1.0M$1.0M$1.0M$0$0$0$0$0$0$1.0M
Fixed Assets$4.0M$3.0M$2.0M$0$0$3.0M$3.0M$2.0M$1.0M$1.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$1.0M$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$7.0M$5.0M$4.0M$2.0M$1.0M$3.0M$5.0M$3.0M$4.0M$8.0M
Current Liabilities$6.0M$5.0M$4.0M$2.0M$1.0M$1.0M$4.0M$2.0M$4.0M$3.0M
Borrowings$0$0$0$0$0$2.0M$2.0M$1.0M$1.0M$0
Other Liabilities$7.0M$5.0M$4.0M$2.0M$1.0M$1.0M$3.0M$1.0M$3.0M$8.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$62.0M$45.0M$36.0M$27.0M$39.0M$30.0M$15.0M$4.0M$10.0M−$1.0M

For VivoSim Labs, Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $11.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow−$29.0M−$29.0M−$20.0M−$15.0M−$13.0M−$8.0M−$12.0M−$15.0M−$9.0M−$11.0M
Investing Cash Flow−$3.0M−$1.0M$0$1.0M−$1.0M−$1.0M−$1.0M$1.0M$9.0M$0
Financing Cash Flow$1.0M$1.0M$0$0$0$0$0$0$0$0
Net Cash Flow$1.0M−$19.0M−$7.0M−$9.0M$10.0M−$9.0M−$13.0M−$12.0M$8.0M−$6.0M
Free Cash Flow−$31.0M−$29.0M−$20.0M−$15.0M−$14.0M−$9.0M−$13.0M−$15.0M−$9.0M−$11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.59
FCF Yield-487.87%
Quick Ratio3.49
Interest Coverage-1001.00
Return 1Y-94.74%
Return 3Y-99.28%
Return 5Y-99.80%

VivoSim Labs, Inc. (VIVS) financials — frequently asked questions

What is VivoSim Labs, Inc.'s annual revenue?

VivoSim Labs, Inc. (VIVS) reported annual revenue of $0 in its most recent fiscal year.

What is VivoSim Labs, Inc.'s net profit?

VivoSim Labs, Inc. (VIVS) reported a net loss of $14.0M in its most recent fiscal year.

What is VIVS EV/EBITDA?

VivoSim Labs, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.59.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
VIVS Overview VIVS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.